Clover Biopharmaceuticals
Research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies.
Launch date
Employees
Market cap
$32.6m
Enterprise valuation
($25m) (Public information from Sep 2024)
Share price
HKD0.225 2197.HK
Chengdu Sichuan (HQ)
Authorizing premium user...